{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:10:30Z","timestamp":1784545830197,"version":"3.55.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Facial seborrheic dermatitis (FSD), also called facial seborrheic eczema, is a common disease affecting both male and female patients worldwide. Tanshinone is the main bioactive component extracted from the Traditional Chinese Medicine <jats:italic>Salvia miltiorrhiza Bunge<\/jats:italic>, which is widely used in treating skin inflammatory diseases. It is necessary to evaluate the clinical evidence for tanshinone capsule treatment of FSD. This study aimed to evaluate the safety and effectiveness of tanshinone capsules combined with prednisone in the treatment of facial seborrheic dermatitis and to provide evidence for clinical practice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Studies were searched in PubMed, the Cochrane Library, the Chinese Biomedical Literature Database, the China National Knowledge Infrastructure, the Chinese Scientific Journal Database, and WanFang Database before October 2021. We also searched for randomized controlled clinical trials (RCT) of tanshinone capsules combined with prednisone on facial seborrheic dermatitis. The meta-analysis was conducted according to the guidelines of the Cochrane Handbook. Two reviewers regulated the research selection, data extraction, and risk of bias assessment, respectively, and a third reviewer was used for consulting when necessary. Review Manager Software 5.3 was used for meta-analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 10 RCTs with 916 participants were included. Nine studies reported total effectiveness, five studies reported symptom score, seven studies reported adverse events, and four studies reported recurrence rate. The duration of treatment was 4 to 8 weeks. Combination therapy showed better clinical effects compared to the prednisone (OR: 5.82; 95% CI: 3.53, 9.59; <jats:italic>p<\/jats:italic> &amp;lt; 0.00001). Combination therapy could repair skin lesions (MD: \u22120.40; 95% CI: \u22120.51, \u22120.30; <jats:italic>p<\/jats:italic> &amp;lt; 0.00001), reduce skin erythema (MD: \u22120.58, 95% CI: \u22120.67, \u22120.49; <jats:italic>p<\/jats:italic> &amp;lt; 0.00001), relieve skin itch (MD: \u22120.70; 95% CI \u22120.77, \u22120.63; <jats:italic>p<\/jats:italic> &amp;lt; 0.00001), and desquamation score (MD: \u22120.64; 95% CI: \u22120.71, \u22120.56; <jats:italic>p<\/jats:italic> &amp;lt; 0.00001). Furthermore, combination therapy could reduce adverse events (OR: 0.46; 95% CI: 0.26, 0.84; <jats:italic>p<\/jats:italic> = 0.01) and control recurrence rate (OR: 0.22; 95% CI: 0.13, 0.36; <jats:italic>p<\/jats:italic> &amp;lt; 0.00001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Compared with prednisone, tanshinone capsules combined with prednisone may be effective in the treatment of facial seborrheic dermatitis. However, due to the high risk and ambiguity of bias in the included trials, the conclusion of this study must be interpreted carefully.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.816419","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T07:01:15Z","timestamp":1651215675000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Tanshinone Capsules Combined With Prednisone for Facial Seborrheic Dermatitis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials"],"prefix":"10.3389","volume":"9","author":[{"given":"Qiang","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengya","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fujun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1080\/09546634.2018.1473554","article-title":"Treatment of seborrheic dermatitis: a comprehensive review","volume":"30","author":"Borda","year":"2019","journal-title":"J Dermatolog Treat."},{"key":"B2","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/bjd.18307","article-title":"Seborrhoeic dermatitis - understood or understudied?","volume":"181","author":"Andersen","year":"2019","journal-title":"Br J Dermatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1177\/0956462416641816","article-title":"Diffuse HIV-associated seborrheic dermatitis - a case series","volume":"27","author":"Forrestel","year":"2016","journal-title":"Int J STD AIDS."},{"key":"B4","first-page":"185","article-title":"Diagnosis and treatment of seborrheic dermatitis","volume":"91","author":"Clark","year":"2015","journal-title":"Am Fam Phys"},{"key":"B5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jdin.2020.10.006","article-title":"Burden of skin disease and associated socioeconomic status in Asia: A cross-sectional analysis from the global burden of disease study 1990-2017","volume":"2","author":"Urban","year":"2020","journal-title":"JAAD Int"},{"key":"B6","doi-asserted-by":"publisher","first-page":"AB190","DOI":"10.1016\/j.jaad.2020.06.848","article-title":"17019 screening of depressive disorders in a group of patients with seborrheic dermatitis of a dermatologic center of Bogot\u00e1, Colombia","volume":"83","author":"Molina","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1186\/s12955-020-01558-y","article-title":"Clinical characteristics and quality of life in seborrheic dermatitis patients: a cross-sectional study in China","volume":"18","author":"Xuan","year":"2020","journal-title":"J Health Qual Life Outcomes."},{"key":"B8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/bs.apha.2019.10.001","article-title":"Pharmacological properties of tanshinones, the natural products from Salvia miltiorrhiza","volume":"87","author":"Wang","year":"2020","journal-title":"Adv Pharmacol"},{"key":"B9","first-page":"10816","article-title":"Clinical efficacy of tanshinone capsules combined with varying concentrations of 5-ALA-PDT in the treatment of cystic acne","volume":"13","author":"Yao","year":"2021","journal-title":"Am J Transl Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"110599","DOI":"10.1016\/j.biopha.2020.110599","article-title":"Pharmacological basis of tanshinone and new insights into tanshinone as a multitarget natural product for multifaceted diseases","volume":"130","author":"Li","year":"2020","journal-title":"Biomed Pharmacother."},{"key":"B11","doi-asserted-by":"publisher","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ."},{"key":"B12","first-page":"187","article-title":"Chapter 8: assessing risk of bias in included studies","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011), The Cochrane Collaboration.","author":"Higgins","year":"2011"},{"key":"B13","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"B14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.16458\/j.cnki.1007-0893.2020.16.018","article-title":"Tanshinone combined with triamcinolone and econazole cream in the treatment of facial seborrheic dermatitis","volume":"30","author":"Guan","year":"2020","journal-title":"J Shenzhen J Integrat Trad West Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3969\/j.issn.1002-1310.2020.03.038","article-title":"Clinical analysis of tanshinone combined with triamcinolone and econazole cream in the treatment of facial seborrheic dermatitis","volume":"42","author":"Wen","year":"2020","journal-title":"Dermatol J Venereol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.3969\/j.issn.1004-437X.2019.18.058","article-title":"Tanshinone capsule combined with triamcinolone econazole cream in the treatment of facial seborrheic dermatitis","volume":"28","author":"Li","year":"2019","journal-title":"J Henan Med Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3969\/j.issn.1672-8351.2019.02.086","article-title":"Tanshinone capsule combined with triamcinolone econazole cream in the treatment of 41 cases of facial seborrheic dermatitis","volume":"16","author":"Wang","year":"2019","journal-title":"J North Pharm."},{"key":"B18","doi-asserted-by":"publisher","first-page":"167","DOI":"10.16281\/j.cnki.jocml.2018.89.128","article-title":"Clinical observation of tanshinone capsule combined with triamcinolone econazole cream in treatment of facial seborrheic dermatitis","volume":"5","author":"Chen","year":"2018","journal-title":"J Clin Med Liter."},{"key":"B19","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3969\/j.issn.1007-3205.2018.03.017","article-title":"Clinical effect of perisone combined with tanshinone in the treatment of facial seborrheic dermatitis","volume":"39","author":"Liu","year":"2018","journal-title":"J Hebei Med Univer."},{"key":"B20","unstructured":"Clinical study of tanshinone capsule combined with triamcinolone econazole in the treatment of facial seborrheic dermatitis867\n            QinN\n          J Health Req312020"},{"key":"B21","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3760\/cma.j.issn.1007-1245.2017.04.035","article-title":"Clinical efficacy of triamcinolone econazole combined with tanshinone in treatment of facial seborrheic dermatitis","volume":"23","author":"Wang","year":"2017","journal-title":"J Int Med Health Guid News"},{"key":"B22","unstructured":"Efficacy of tanshinone combined with triamcinolone econazole cream in the treatment of facial seborrheic dermatitis232\n            LuDD\n          J Health Req20212021"},{"key":"B23","unstructured":"Efficacy of tanshinone capsule combined with triamcinolone econazole cream in the treatment of facial seborrheic dermatitis212\n            YouCP\n          J Health Horizon.20202020"},{"key":"B24","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s13555-019-00319-0","article-title":"Topical non-pharmacological treatment for facial seborrheic dermatitis","volume":"9","author":"Piquero-Casals","year":"2019","journal-title":"Dermatol Ther."},{"key":"B25","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/myc.12456","article-title":"Isolation and identification of malassezia species from Chinese and Korean patients with seborrheic dermatitis and in vitro studies on their bioactivity on sebaceous lipids and IL-8 production","volume":"59","author":"Kim","year":"2016","journal-title":"Mycoses."},{"key":"B26","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/mmy\/myaa050","article-title":"Sociodemographic characteristics and spectrum of malassezia species in individuals with and without seborrhoeic dermatitis\/dandruff: a comparison of residents of the urban and rural populations","volume":"59","author":"Honnavar","year":"2021","journal-title":"Med Mycol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/exd.14091","article-title":"An update on the microbiology, immunology and genetics of seborrheic dermatitis","volume":"29","author":"Adalsteinsson","year":"2020","journal-title":"Exp Dermatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.11786\/sypfbxzz.1674-1293.20170112","article-title":"Research advances of pathogenesis of seborrheic dermatitis","volume":"10","author":"Zhu","year":"2017","journal-title":"J Pract Dermatol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.clindermatol.2013.05.032","article-title":"Red face revisited: endogenous dermatitis in the form of atopic dermatitis and seborrheic dermatitis","volume":"32","author":"Ramos-E-Silva","year":"2014","journal-title":"Clin Dermatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.3906\/sag-1906-72","article-title":"Serum zinc levels in seborrheic dermatitis: a case-control study","volume":"49","author":"Akta\u015f Karabay","year":"2019","journal-title":"Turk J Med Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3969\/j.issn.1674-8468.2020.04.006","article-title":"Macrogenomic analysis of flora changes in facial seborrheic dermatitis","volume":"27","author":"Zhong","year":"2020","journal-title":"J Dermatol Diag Venereol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s00449-020-02333-5","article-title":"Malassezia and Staphylococcus dominate scalp microbiome for seborrheic dermatitis","volume":"44","author":"Lin","year":"2021","journal-title":"Bioproc Biosyst Eng."},{"key":"B33","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.jid.2017.11.020","article-title":"The genetics of seborrheic dermatitis: a candidate gene approach and pilot genome-wide association study","volume":"138","author":"Sanders","year":"2018","journal-title":"J Invest Dermatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s40257-016-0232-2","article-title":"Topical treatment of facial seborrheic dermatitis: a systematic review","volume":"18","author":"Gupta","year":"2017","journal-title":"Am J Clin Dermatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"CD009446","DOI":"10.1002\/14651858.CD009446.pub2","article-title":"Topical anti-inflammatory agents for seborrhoeic dermatitis of the face or scalp","volume":"2014","author":"Kastarinen","year":"2014","journal-title":"Cochrane Database Syst Rev."},{"key":"B36","first-page":"329","article-title":"Topical medications for seborrheic dermatitis","volume":"95","author":"Baumert","year":"2017","journal-title":"Am Fam Phys."},{"key":"B37","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3389\/fphar.2019.00202","article-title":"Tanshinones, critical pharmacological components in Salvia miltiorrhiza","volume":"10","author":"Jiang","year":"2019","journal-title":"Front Pharmacol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fphar.2020.00193","article-title":"The anticancer properties of tanshinones and the pharmacological effects of their active ingredients","volume":"11","author":"Fu","year":"2020","journal-title":"Front Pharmacol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1111\/cbdd.13567","article-title":"Synthesis of novel tanshinone derivatives for treatment of castration-resistant prostate cancer","volume":"94","author":"Xu","year":"2019","journal-title":"Chem Biol Drug Des."},{"key":"B40","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.foodchem.2018.07.098","article-title":"In vitro and in silico perspectives on estrogenicity of tanshinones from Salvia miltiorrhiza","volume":"270","author":"Zhang","year":"2019","journal-title":"Food Chem"},{"key":"B41","doi-asserted-by":"publisher","first-page":"106040","DOI":"10.1016\/j.intimp.2019.106040","article-title":"A network pharmacology approach to investigate the anti-inflammatory mechanism of effective ingredients from Salvia miltiorrhiza","volume":"81","author":"Cui","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e12716","DOI":"10.1111\/dth.12716","article-title":"The therapeutic effect of tanshinone IIA on propionibacterium acnes-induced inflammation in vitro","volume":"31","author":"Li","year":"2018","journal-title":"Dermatol Ther."},{"key":"B43","first-page":"721","article-title":"Topical application of sulfotanshinone sodium suppresses sebaceous hyperplasia in Syrian hamsters","volume":"151","author":"Gozali","year":"2016","journal-title":"G Ital Dermatol Venereol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"4735","DOI":"10.2147\/DDDT.S266911","article-title":"Pharmacological activity and mechanism of tanshinone iia in related diseases","volume":"14","author":"Guo","year":"2020","journal-title":"Drug Des Dev Ther."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.816419\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T07:03:13Z","timestamp":1651215793000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.816419\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,29]]},"references-count":44,"alternative-id":["10.3389\/fmed.2022.816419"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.816419","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,29]]},"article-number":"816419"}}